Bariga, Rizel .

HRN: 23-54-32  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2023
CEFUROXIME 1.5GM (VIAL)
08/19/2023
08/21/2023
IV
1.5grams
Q8hrs
For STAT CS
Checking Final Appropriateness 
08/19/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/19/2023
08/21/2023
IV
500mg
Q8hrs
For STAT CS, Thickly MSAF
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: